We believe pairing HLA typing with SARS-CoV-2 sequencing and testing anti-S protein CD8 T cell responses could allow precise assessment of clinical outcome of D614/G614 virus infection on individuals with different HLA alleles. Here, CD8A is linked to viral infectious disease.